ArticleCureus2025
A Challenging Diagnosis of Laryngeal Neuroendocrine Tumor (NET): Final Classification as NET Grade 3 After Total Laryngectomy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laryngeal neuroendocrine neoplasms (NENs) are rare tumors that account for a small proportion of all laryngeal malignancies. They exhibit a wide range of differentiation and proliferative activity, and are often graded accordingly, using markers such as mitotic count and Ki-67 labeling index. We present the case of a 76-year-old man with progressive dysphagia and a supraglottic mass. Initial biopsy findings were inconclusive, raising suspicion of poorly differentiated carcinoma or metastatic disease. A re-biopsy of the larynx under general anesthesia and neck dissection revealed features consistent with neuroendocrine tumor (NET) Grade 2 (Ki-67 index 17%). Due to the limited efficacy of nonsurgical treatments and absence of somatostatin receptor expression, total laryngectomy was performed. Histopathological analysis of the resected specimen demonstrated increased mitotic activity and a Ki-67 index of 28%, leading to a revised diagnosis of NET Grade 3. This case highlights the diagnostic limitations of small biopsy specimens in the head and neck region and underscores the importance of stepwise evaluation, including surgical pathology, in establishing an accurate diagnosis and guiding curative treatment decisions in rare laryngeal NETs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.